MedPath

A phase I trial of stereotactic body radiotherapy for limited hepatocellular carcinoma

Phase 1
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000003090
Lead Sponsor
Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1) Uncontrolled ascites 2) Gastric/esophageal varix which needs preventive treatment 3) Tumor thrumbus in main trunk of portal vein or IVC 4) Case with critical complication 5) Simultaneous cancer 6) In pregnancy or with expectation of pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath